Boys Town National Research Hospital (BTNRH) Genetic & Molecular Biology Labs Auditory Neurobiology Vestibular Neurogenetics Neurochemistry Retinal Neurobiology.

Slides:



Advertisements
Similar presentations
Eri Hashino Ph.D. in Neurobiology, Nagoya Univ., Japan –Hair Cell Regeneration Postdoctoral Fellowships at SUNY at Buffalo –Hair Cell Regeneration –Neurotrophic.
Advertisements

Functional autoradiography: Incorporation of [ 35 S]-GTP γ S In vitro target function [ 35 S]GTPγS X.
IDENTIFICATION OF THE MOLECULAR MECHANISMS IN RETT SYNDROME AND RELATED DISORDERS (RTT-GENET) X.
Cancer Biology. 2 Outline 1.How do cancer cells differ from normal cells? Tumor progression Molecular basis for cancer.
Tissue Repair Dr. Raid Jastania. What is Repair? When does regeneration occur? When does fibrosis occur? What are the consequences of fibrosis?
AT 4 Receptor Ligands as Angiogenic, Anti-angiogenic, and Anti-cancer Agents How do you translate basic science into a clinically useful technology?
Von Hippel-Lindau Syndrome (VHL) Presented by Kelley Montoya March 20, 2003.
 MicroRNAs (miRNAs) are a class of small RNA molecules, about ~21 nucleotide (nt) long.  MicroRNA are small non coding RNAs (ncRNAs) that regulate.
Protein Mutations in Disease Lecture 11, Medical Biochemistry.
RET Proto- Oncogene in The Development of Thyroid Cancer: Multiple Endocrine Neoplasia Type 2 Courtney Brooks.
Cell Biology Course Info and Introduction. What is Cell Biology? Investigation of Biological Systems –Biochemistry –Molecular Biology –Genetics/Molecular.
MBBS Cancer Biology Module 2006 Tumour Vasculature and Therapeutic Strategies Barbara Pedley.
CELL SIGNALING. THREE LEVELS OF CONTACT WITH ENVIRONMENT.
Cellular adhesion molecules and the extracellular matrix
Malignant Melanoma and CDKN2A
Chromosome 10 Researched by: Ashley Thorne 136M base pairs 1305 total genes on chromosome AND…the entire chromosome has been sequenced since 2004!!
AMPAKINE Compounds for the Treatment of Rett Syndrome
Cancer What is cancer? How does it form? How can it be treated?
Presented By: Lana Awad and Sebastian Lukjan. Motivation of research, why they did what they did…  Understand steps that cancer cells take to spread.
Cellular Responses What are the four components of repair? Angiogenesis Migration and proliferation of fibroblasts Deposition.
STAT3 and the Immune System Maureen Sherry Lynes February 29, 2012.
Angiogenesis ↓ Metastasis. Angiogenesis--- The process of developing new blood vessels. Cancer cells (probably like all tissues) secrete substances that.
Control of Gene Activity Chapter 17. Controlling gene activity Remember to control the cell one must control protein synthesis. Remember to control the.
Characterization of the anti-angiogenic properties of arresten,an α1β1 integrin- dependent collagen-derived tumor suppressor E xperimental Cell Research.
Characteristics of Cancer. Promotion (reversible) Initiation (irreversible) malignant metastases More mutations Progression (irreversible)
Rachel Drake, University of Minnesota Jennifer Phillips, University of Oregon Westerfield Lab M. Pyron,
Disorders Associated with G protein-Coupled Receptors
Computational biology of cancer cell pathways Modelling of cancer cell function and response to therapy.
Pavel Yarmolenko Biology 169, Spring 2005 The von Hippel-Lindau (VHL) Tumor Suppressor Gene Inactivation and Its Involvement in Tumorgenesis.
Understanding deafness in the Usher syndrome: A possible interaction between Grxcr1 and the zebrafish Usher complex Jennifer M. Panlilio Westerfield Lab.
HORMONES June 4, Interactive homeostatic system: communication between body and brain by means of neurons and factors circulating in blood.
Essentials of Biology Sylvia S. Mader
Cytokines Basic introduction. Contents Definition General characteristics Types of cytokines Cytokine receptors and their types Biological functions of.
BRG-1 in Cancer BRG-1 is an ATPase subunit of the SWI/SNF class of chromatin remodeling complexes It has been found mutated in a number of cancer cell.
Steve MacLean, Romualdo Ancog, Zoe Bowers, Elise Schellpfeffer (Clip Art)
Craig D. Woodworth, Evan Michael, Laura Smith, and Matthias Nees. Department of Biology, Clarkson University, Potsdam, NY, USA, and Department of Pediatric.
Cell Communication Chapter Cell Communication: An Overview  Cells communicate with one another through Direct channels of communication Specific.
Sensory Receptors. (a) Receptor is afferent neuron.(b) Receptor regulates afferent neuron. To CNS Afferent neuron To CNS Receptor protein Sensory receptor.
Repair 2 Dr Heyam Awad FRCpath.
Two powerful transgenic techniques Addition of genes by nuclear injection Addition of genes by nuclear injection Foreign DNA injected into pronucleus of.
Lecture 12: Cancer: a cellular perspective Dr. Mamoun Ahram Faculty of Medicine Second year, Second semester, Principles of Genetics and Molecular.
Mentor: Jennifer Phillips, PhD University of Oregon- SPUR Program
TSC1/Hamartin and Facial Angiofibromas Biology 169 Ann Hau.
Elena Klenova CTCF and BORIS in normal development, epigenetics and tumourigenesis Areas of research: Molecular Oncology Gene regulation Translational.
PTEN (Cowden Syndrome) /.../ sld083.htm.
PTEN (Phosphatase and Tensin Homolog) a.k.a. MMAC1, TEP1 Raymond Stadiem.
Inhibition of microfibrillar-associated protein 4 as a potential therapy targeting choroidal neovascularization in age-related macular degeneration Bartosz.
Regulating the Cell Cycle Chapter 12.3 Cellular Biology.
SC430 Molecular Cell Biology Welcome to Unit 7 Seminar with Dr Hall-Pogar Tonight we will discuss –Diseases that result from errors in cell signaling pathways.
Chapter 7 Neoplasia.
A novel bispecific ligand-directed toxin designed to simultaneously target EGFR on human glioblastoma cells and uPAR on tumor neovasculature Brandon Kats.
Inflammation (1 of 5) Ali Al Khader, M.D. Faculty of Medicine
Arne R. M. van der Bilt, Elisabeth G. E
Angiogenesis and hepatocellular carcinoma
Peter John M.Phil, PhD Atta-ur-Rahman School of Applied Biosciences (ASAB) National University of Sciences & Technology (NUST)
p57 & Beckwith-Weidemann Syndrome
TSC2 GENE ENCODES FOR TUBERIN
Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis
M.B.Ch.B, MSC, DCH (UK), MRCPCH
PTEN (a.k.a. MMAC1 and TEP1) and Cowden’s Disease
Cancer stem cells and their application into targeted therapy for cancer Mol. Bio. Lab Park Ji Won Supervisor ; Dae Youn Hwang.
Volume 71, Issue 3, Pages (February 2007)
Hearing Impairment: A Panoply of Genes and Functions
Nat. Rev. Rheumatol. doi: /nrrheum
PTEN Tumor Suppressor and Cancer
Angiogenesis and hepatocellular carcinoma
Protein kinase Cα: disease regulator and therapeutic target
Fig. 5. An illustration showing roles or functions of analyzed retinal disease-related genes. An illustrationshowing roles or functions of analyzed retinal.
Cell Signal Transduction and Diseases
Empty basement membrane sleeves and endothelial sprouts.
Presentation transcript:

Boys Town National Research Hospital (BTNRH) Genetic & Molecular Biology Labs Auditory Neurobiology Vestibular Neurogenetics Neurochemistry Retinal Neurobiology Gene Expression Lymphatic Research Gene Marker & Identification Cell Signaling & Angiogenesis

Goal is to understand the basic mechanisms underlying auditory system development in normal and pathological systems.  Role of thyroid hormone in cochlear development  Role of Vlgr1 in stereociliary bundle development  Development of amino acid neurotransmission among neurons of the caudal brainstem Auditory Neurobiology Lab Edward Walsh, JoAnn McGee Hz dB SPL

Techniques  Single cell electrophysiology  Evoked potential  Sensory cell transduction  Inner ear and CNS histology and ultrastructure  Immunocytochemistry and histochemistry  Otoacoustic emissions  Microiontophoresis Auditory Neurobiology Lab Edward Walsh, JoAnn McGee

Goal is to identify the molecular and biochemical mechanisms by which endogenous angiogenesis inhibitors prevent tumor development and growth  Identify the mechanism through which the carboxy terminal of type IV collagen, specifically, the noncollagenous domain 1 of the  1 chain of type IV collagen (  1(IV)NC1), inhibits angiogenesis and tumor growth (type IV collagen is the major component of vascular basement membranes)  Determine mechanism whereby  1β1 integrin regulates hypoxia- associated factors associated with the antiangiogenic activity of  1(IV)NC1  Identify the cell signaling pathway involved in the non-integrin mediated antiangiogenic activity of a1(IV)NC1  Identify natural proteins that can be used as therapeutic agents for the treatment of cancer Cell Signaling & Angiogenesis Lab Sudhakar Akulapalli

Techniques  In vivo tumor burden studies  Cell culture systems (mouse lung endothelial cells, mouse lung fibroblast preparations)  Migration and proliferation assays  Immunoprecipitation and immunoblotting to study protein interactions  Immunohistochemistry Sudhakar et al. (2005) Cell Signaling & Angiogenesis Lab Sudhakar Akulapalli

Study of molecular mechanisms underlying progressive pathologies resulting from mutations in basement membrane proteins; the role(s) of cell adhesion and integrin signaling proteins, cytokines and chemokines  Alport Syndrome (Type IV collagen)  Renal pathology  Inner ear pathology  Usher Syndrome Type IIa (Usherin)  Retinal pathology  Inner ear pathology Gene Expression Lab Dominic Cosgrove, Velidi Rao

Techniques  Gene knockout mouse models for Alport syndrome and Usher syndrome type IIa  Immortalized cell lines derived from the retina, the stria vascularis, and the renal glomerulus of both normal and mutant mice  Biochemical and molecular techniques  Treatment strategies

Identification of genes associated with hearing loss and localization to the human gene map  Syndromic:  Usher Syndrome (Type I, Type II and Type III)  Branchio-Oto-Renal (BOR) Syndrome  Cleft Palate  Nonsyndromic:  Dominant Progressive Hearing Loss  Autosomal Recessive Hearing Loss (Auditory Neuropathy – otoferlin) Gene Marker & Identification Lab Bill Kimberling, Dana Orten, Phil Kelley Usher Syndrome USH1b – myosin VIIa USH1c – harmonin USH1d – cadherin 23 USH1f – protocadherin 15 USG1g - sans USH2a – usherin USH2c – vlgr1 USH3 – clarin1 Hereditary Hearing Loss Syndromic (20%) Usher Syndrome Nonsyndromic (80%) Dominant (15%) Recessive (80%)

Gene Marker & Identification Lab Bill Kimberling, Dana Orten, Phil Kelley Techniques  Construct physical maps of the critical region of the human genome associated with hearing loss, identify candidate genes in that region, and search for mutations in candidate genes  Linkage mapping and haplotype mapping to identify regions of human genome linked to hearing loss genes  Positional candidate cloning strategy to identify genes causing hearing loss  Treatment strategies

Study of the lymphatic system as it relates to human inflammatory and malignant disease. Study of the molecules and mechanisms that contribute to lymphatic growth assessed by lymphangiogenesis Lymphatic vessels drain extracellular fluid and improve the capacity for pathogen surveillance by directing fluid towards regional lymph nodes Lymphatic Research Laboratory Richard Tempero

Techniques  Murine model of respiratory inflammation (e.g., Mycoplasma pulmonis infection)  Study molecules and mechanisms important for lymphangiogenesis Confocal image of normal mouse trachea lymphatics (LYVE-1 red) blood vessels (CD31 green) Lymphatic Research Laboratory Richard Tempero

The role of neurotransmitters and receptors in the establishment of neural pathways and the formation of maintenance of synaptic connections.  The role of acetylcholine and acetylcholinesterase in the development and maturation of the primary neurotransmitters in the auditory brainstem.  Understanding how acetylcholine drives the auditory system before the onset of hearing.  Understanding how nicotinic acetylcholine receptors function in outer hair cells and spiral ganglion cells. Neurochemistry Lab Barbara Morley

Techniques  Pharmacological and immuno- cytochemical characterization of neurotransmitter receptor subunits and assembled receptors  Expression of receptor subunits using in situ hybridization and real time RT-PCR  Construction of mice and cell lines that are have null mutations for cochlea-specific genes Neurochemistry Lab Barbara Morley

Molecular mechanisms of hereditary retinal degeneration, particularly retinitis pigmentosa  Mechanism of retinal degeneration in Usher syndrome type IIa; the role of usherin in cell signaling  Mechanism by which rod-specific genetic disorders lead to the degeneration of genetically-normal cone photoreceptors  Role of plasticity in bipolar cell connections during retinal degeneration Retinal Neurobiology Lab You-Wei Peng

Techniques  Immunofluorescence  In situ hybridization  Real time RT-PCR  Retinal histology and ultrastructure Rod marker, rhodopsin (red), Cone marker, cone transducin γ (green)

Study of the molecular and cellular mechanisms of otoconia development in the vestibular system Otoconia are composite crystals that overlie and provide optimal stimulus input to the sensory epithelium of the balance system. The crystals are critical for spatial orientation and balance. Vestibular Neurogenetics Lab Yesha Lundberg Deletion of Oc90 gene leads to abnormal otoconia formation and balance deficits

Vestibular Neurogenetics Lab Yesha Lundberg Techniques  Gene targeting  Protein biochemistry  Histological and ultrastructural analyses  Cell culture  Physiological studies (collaborative)

 Lymphatic Research  R Tempero  Neurochemistry  B Morley  Retinal Neurobiology  Y Peng  Vestibular Neuro- genetics  Y Lundberg BTNRH: Genetic and Molecular Biology Laboratories  Auditory Neurobiology  E Walsh, J McGee  Cell Signaling and Angiogenesis  S Akulapalli  Gene Expression  D Cosgrove, V Rao  Gene Mapping and Identification  B Kimberling, D Orten, P Kelley